Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2017 | Pharmacovigilance and the purpose of clinical trials

Diana Lüftner, from the Humboldt University, Berlin, Germany speaks to us from the 2017 European Society for Medical Oncology (ESMO) conference held in Madrid, Spain, discussing clinical trials from a clinician’s point of view. Prof. Lüftner explains their purpose and what clinicians look for in a trial, and tells us the importance of reducing drug interchangeability during a patient’s course of treatment.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.